Download PDF
Rofo 2015; 187(1): 19-28
DOI: 10.1055/s-0034-1385081
Review
© Georg Thieme Verlag KG Stuttgart · New York

Indication and Technical Aspects of Adrenal Blood Sampling

Indikationen und Technik der selektiven Nebennierenvenenblutentnahme
D. Blondin
1   Department of Radiology, Medical Faculty HHU, Düsseldorf,
2   Department of Radiology and Nuclear Medicine, Städtische Kliniken Mönchengladbach
,
I. Quack
3   Department of Nephrology, University Hospital Düsseldorf, Medical Faculty HHU, Düsseldorf
,
M. Haase
4   Department of Endocrinology and Diabetology, University Hospital Düsseldorf, Medical Faculty HHU, Düsseldorf
,
S. Kücükköylü
3   Department of Nephrology, University Hospital Düsseldorf, Medical Faculty HHU, Düsseldorf
,
H. S. Willenberg
4   Department of Endocrinology and Diabetology, University Hospital Düsseldorf, Medical Faculty HHU, Düsseldorf
› Author Affiliations
Further Information

Publication History

10 February 2014

23 July 2014

Publication Date:
16 September 2014 (online)

Also available at
   Permissions and Reprints

Abstract

Adrenal disorders are relative frequent with regard to the incidence of adrenal tumors and the high portion in causes of secondary hypertension. Morphological changes in the adrenal glands can lead to very different functional disorders that may be clinically overt or hard to diagnose. On the other hand, they can already be functionally relevant when structural changes are too small to be picked up by imaging. Adrenal venous sampling serves to determine the source of hormone excess through the analysis of adrenal blood. In this manuscript, we call attention to the clinical backgrounds, critical points in praxis, technical aspects and developments in the the field of adrenal venous sampling. The consideration of these important points in the clincal setting may make adrenal vein sampling studies sucessful and help to select patients that qualify for adrenalectomy.

Key Points:

• Selective adrenal venous sampling (AVS) currently continues to be the gold standard for localization diagnostics in patients with primary hyperaldosteronism.

• Comprehensive standardization of all preceding examinations and AVS is necessary to ensure high success rates.

• The method is supported by contrast-enhanced imaging for ensuring proper positioning of the catheter in the adrenal veins and the rapid cortisol assay.

• Knowledge of the anatomy and normal variants of the adrenal veins facilitates adrenal venous sampling.

Citation Format:

• Blondin D, Quack I, Haase M et al. Indication and Technical Aspects of Adrenal Blood Sampling. Fortschr Röntgenstr 2015; 187: 19 – 28

Zusammenfassung

Nebennierenerkrankungen sind unter Berücksichtigung der Inzidenzen von Nebennierentumoren und hormonellen Ursachen als prävalenteste sekundäre Hypertonieformen relativ häufig. Morphologische Veränderungen der Nebennieren können zu ganz unterschiedlichen sichtbaren oder kaum messbaren Funktionsstörungen führen. Andererseits können sich Funktionsstörungen klinisch bereits bemerkbar machen, wenn strukturelle Veränderungen der Nebennieren in der Schnittbildgebung noch nicht erfasst werden. Der selektive Nebennierenvenenkatheter dient der Gewinnung adrenalen Blutes, um die Quelle eines Hormonexzesses zu identifizieren. In dieser Arbeit wird auf Hintergründe, Fallstricke, technische Aspekte und Entwicklungen der Nebennierenvenenkatheterdiagnostik eingegangen. Deren Beachtung in der klinischen Praxis kann die Nebennierenvenenblutentnahme zu einer erfolgreichen Prozedur machen und damit helfen, Patienten zu selektieren, die von einer Adrenalektomie profitieren.

Key words

abdomen - adrenal gland - angiography - endocrine disorders

Deutscher Artikel/German Article

 

  • Literatur

  • 1 Catena C, Colussi G, Di Fabio A et al. Mineralocorticoid antagonists treatment versus surgery in primary aldosteronism. Horm Metab Res 2010; 42: 440-445
    Google Scholar
  • 2 Sechi LA, Colussi G, Di Fabio A et al. Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment. Am J Hypertens 2010; 23: 1253-1260
    Google Scholar
  • 3 Fourkiotis VG, Vonend O, Diederich S et al. Effectiveness of Eplerenone or Spironolactone treatment in preserving renal function in primary aldosteronism. Eur J Endocrinol 2012; 168: 75-81
    CrossrefPubMedGoogle Scholar
  • 4 Fardella CE, Mosso L, Gomez-Sanchez C et al. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 2000; 85: 1863-1867
    CrossrefPubMedGoogle Scholar
  • 5 Mulatero P, Stowasser M, Loh KC et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004; 89: 1045-1050
    Google Scholar
  • 6 Rossi GP, Bernini G, Caliumi C et al. A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients. J Am Coll Cardiol 2006; 48: 2293-2300
    Google Scholar
  • 7 Douma S, Petidis K, Doumas M et al. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 2008; 371: 1921-1926
    Google Scholar
  • 8 Quack I, Vonend O, Rump LC. Familial hyperaldosteronism I-III. Horm Metab Res 2010; 42: 424-428
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Beuschlein F. Regulation of aldosterone secretion: from physiology to disease. Eur J Endocrinol 2013; 168: 85-93
    CrossrefPubMedGoogle Scholar
  • 10 Zennaro MC, Rickard AJ, Boulkroun S. Genetics of mineralocorticoid excess: an update for clinicians. Eur J Endocrinol 2013; 169: 15-25
    CrossrefPubMedGoogle Scholar
  • 11 Scholl UI, Lifton RP. New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5. Curr Opin Nephrol Hypertens 2013; 22: 141-147
    CrossrefPubMedGoogle Scholar
  • 12 Mansmann G, Lau J, Balk E et al. The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 2004; 25: 309-340
    CrossrefPubMedGoogle Scholar
  • 13 Späth M, Korovkin S, Antke C et al. Aldosterone and cortisol co-secreting adrenal tumours – the lost subtype of primary aldosteronism. Eur J Endocrinol 2011; 164: 447-455
    Google Scholar
  • 14 Milliez P, Girerd X, Plouin PF et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005; 45: 1243-1248
    Google Scholar
  • 15 Stowasser M, Sharman J, Leano R et al. Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. J Clin Endocrinol Metab 2005; 90: 5070-5076
    Google Scholar
  • 16 Funder JW, Carey RM, Fardella C et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008; 93: 3266-3281
    Google Scholar
  • 17 Diederich S, Willenberg HS, Schirpenbach C et al. Trotz Kombinationstherapie bleibt der Blutdruck oben? Häufiger als vermutet ist ein primärer Hyperaldosteronismus schuld. MMW 2010; 152: 32-35
    PubMedGoogle Scholar
  • 18 Willenberg HS, Gruber M, Eisenhofer G et al. Endokrine Hypertonie – Neuigkeiten und jüngste Entwicklungen. Dtsch Med Wochenschr 2012; 137: 627-630
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Gordon RD. Mineralocorticoid hypertension. Lancet 1994; 344: 240-243
    CrossrefPubMedGoogle Scholar
  • 20 Willenberg HS, Vonend O, Schott M et al. Comparison of the saline infusion test and the fludrocortisone suppression test in the diagnosis of primary aldosteronism. Horm Metab Res 2012; 44: 527-532
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Melby JC, Spark RF, Dale SL et al. Diagnosis and localization of aldosterone-producing adenomas by adrenal-vein cateterization. N Engl J Med 1967; 277: 1050-1056
    Google Scholar
  • 22 Stowasser M, Gordon R, Rutherford J et al. Diagnosis and management of primary aldosteronism. JRAAS 2001; 2: 156-169
    PubMedGoogle Scholar
  • 23 Young W, Stanson A, Thompson G et al. Role for adrenal venous sampling in primary aldosteronism. Surgery 2004; 136: 1227-1235
    Google Scholar
  • 24 Vonend O, Stegbauer J, Kokulinsky P et al. Vergleich der Bildgebung und seitengetrennten Nebennierenvenenblutentnahme zur Differentialdiagnose bei primärem Hyperaldosteronismus. DMW 2007; 132: 2436-2441
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Kempers MJ, Lenders JW, van Outheusden L et al. Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. Ann Intern Med 2009; 151: 329-337
    Google Scholar
  • 26 Diederich S, Bidlingsmaier M, Quinkler M et al. Diagnostik des primären Hyperaldosteronismus. Med Klinik 2007; 102: 16-21
    CrossrefPubMedGoogle Scholar
  • 27 Schirpenbach C, Segmiller F, Diederich S et al. The Diagnosis and Treatment of Primary Hyperaldosteronism in Germany – Results on 555 Patients from the German Conn Registry. Dtsch Arztbl Int 2009; 106: 305-311
    PubMedGoogle Scholar
  • 28 Lamas C, Alfaro JJ, Lucas T et al. Is unilateral adrenalectomy an alternative treatment for ACTH-independent macronodular adrenal hyperplasia? Long-term follow-up of four cases. Eur J Endocrinol 2002; 146: 237-240
    CrossrefPubMedGoogle Scholar
  • 29 Iacobone M, Albiger N, Scaroni C et al. The role of unilateral adrenalectomy in ACTH-independent macronodular adrenal hyperplasia (AIMAH). World J Surg 2008; 32: 882-889
    CrossrefPubMedGoogle Scholar
  • 30 Wolf A, Willenberg HS, Cupisti K et al. Adrenal pheochromocytoma with contralateral cortisol-producing adrenal adenoma: diagnosic and therapeutic management. Horm Metab Res 2005; 37: 391-395
    Article in Thieme ConnectPubMedGoogle Scholar
  • 31 Freel EM, Stanson AW, Thompson GB et al. Adrenal venous sampling for catecholamines: a normal value study. J Clin Endocrinol Metab 2010; 95: 1328-1332
    CrossrefPubMedGoogle Scholar
  • 32 Dekkers T, Deinum J, Schultzekool LJ et al. Plasma metanephrine for assessing the selectivity of adrenal venous sampling. Hypertension 2013; 62: 1152-1157
    Google Scholar
  • 33 Nieman LK, Biller BM, Findling JW et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008; 93: 1526-1540
    Google Scholar
  • 34 Quinkler M, Fassnacht M, Petersenn S et al. Pheochromocytoma: current diagnostics and treatment. MMW Fortschr Med 2010; 152: 36-38
    PubMedGoogle Scholar
  • 35 Levens ED, Whitcomb BW, Csokmay JM et al. Selective venous sampling for androgenproducing ovarian pathology. Clin Endocrinol 2009; 70: 606-614
    CrossrefPubMedGoogle Scholar
  • 36 Stewart PM, Allolio B. Adrenal vein sampling for Primary Aldosteronism: time for a reality check. Clin Endocrinol 2010; 72: 146-148
    CrossrefPubMedGoogle Scholar
  • 37 Scholten A, Cisco RM, Vriens MR et al. Variant adrenal venous anatomy in 546 laparoscopic adrenalectomies. JAMA Surg 2013; 148: 378-383
    CrossrefPubMedGoogle Scholar
  • 38 Anson BJ, Cauldwell EW, Pick JW et al. The blood supply of the kidneys, suprarenal gland and associated structures. J Urol 1948; 60: 714-737
    PubMedGoogle Scholar
  • 39 Gagnon R. The venous drainage of the human adrenal gland. Rev Can Biol 1956; 14: 350-359
    PubMedGoogle Scholar
  • 40 Johnstone FR. The suprarenal veins. Am J Surg 1957; 94: 615-620
    CrossrefPubMedGoogle Scholar
  • 41 Monkhouse WS, Khalique A. The adrenal and renal veins of man and their connections with azygos and lumbar veins. J Anat 1986; 146: 105-115
    PubMedGoogle Scholar
  • 42 Bookstein JJ. The roles of angiography in adrenal disease. In Abram’s angiography. 3rd ed. Boston, Mass: Little, Brown; 1983: 1395-1424
    Google Scholar
  • 43 Daunt N. Adrenal Vein Sampling: How to make it quick, easy, and successful. Radiographics 2005; 25: 143-158
    CrossrefPubMedGoogle Scholar
  • 44 Palmowski M, Mühlenbruch G, Grouls C et al. Bilaterale selektive Nebennierenvenen-Blutentnahme: Einzelkatheter-Technik mittels eines 4F-Kobra-Katheters in Standard- und Inversionstechnik. Fortschr Röntgenstr 2011; 187: 167-170
    Article in Thieme ConnectPubMedGoogle Scholar
  • 45 Rossi GP, Auchus RJ, Brown M et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension 2014; 63: 151-160
    Google Scholar
  • 46 Monticone S, Satoh F, Giacchetti G et al. Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling in primary aldosteronism. Hypertension 2012; 59: 840-846
    Google Scholar
  • 47 Willenberg HS, Quinkler M, Fassnacht M. Ohne Synacthen gibt es zurzeit keine ACTH-Tests. Vorschläge für Alternativen von der Sektion Nebenniere, Steroide und Hypertonie der Deutschen Geselschaft für Endokrinologie (DGE). Endokrinologie Informationen 2013; 37: 60-62
    PubMedGoogle Scholar
  • 48 Willenberg HS, Schinner S, Ansurudeen I. New mechanisms to control aldosterone synthesis. Horm Metab Res 2008; 40: 435-441
    Article in Thieme ConnectPubMedGoogle Scholar
  • 49 Auchus RJ, Chandler DW, Singeetham S et al. Measurement of 18-hydroxycorticosterone during adrenal vein sampling for primary aldosteronism. J Clin Endocrinol Metab 2007; 92: 2648-2651
    Google Scholar
  • 50 Nakamura Y, Satoh F, Morimoto R et al. 18-oxocortisol measurement in adrenal vein sampling as a biomarker for subclassifying primary aldosteronism. J Clin Endocrinol Metab 2011; 96: 1272-1278
    CrossrefPubMedGoogle Scholar
  • 51 Seccia TM, Miotto D, Battistel M et al. A stress reaction affects assessment of selectivity of adrenal venous sampling and of lateralization of aldosterone excess in primary aldosteronism. Eur J Endocrinol 2012; 166: 869-875
    CrossrefPubMedGoogle Scholar
  • 52 Mengozzi G, Rossato D, Bertello C et al. Rapid cortisol assay during adrenal vein sampling in patients with primary aldosteronism. Clin Chem 2007; 53: 1968-1971
    Google Scholar
  • 53 Betz MJ, Degenhart C, Fischer E et al. Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates. Eur J Endocrinol 2011; 165: 301-306
    Google Scholar
  • 54 Hennings J, Sundin A, Hägg A et al. 11C-metomidate positron emission tomography after dexamethasone suppression for detection of small adrenocortical adenomas in primary aldosteronism. Langenbecks Arch Surg 2010; 395: 963-967
    Google Scholar
  • 55 Burton TJ, Mackenzie IS, Balan K et al. Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas. J Clin Endocrinol Metab 2012; 97: 100-109
    CrossrefPubMedGoogle Scholar
  • 56 Hahner S, Kreissl MC, Fassnacht M et al. Functional characterization of adrenal lesions using [123I]IMTO-SPECT/CT. J Clin Endocrinol Metab 2013; 98: 1508-1518
    CrossrefPubMedGoogle Scholar